Skip to the page

Data / Drug companies / Rosuvastatin

Rosuvastatin: 19 companies and 69 products in the FDA NDC directory

Rosuvastatin is listed in the FDA National Drug Code Directory by 19 companies, with 69 products in commercial distribution. 65 of the products (94.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, coated; tablet, and the newest product started marketing on July 22, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
19
Products
69
Generic (ANDA) products
65 (94.2%)
Application numbers
8
Routes
Oral
Brand names
Crestor
openFDA record search
api.fda.gov

Companies that list rosuvastatin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions8tablet, film coatedGeneric drugs (ANDA)April 24, 2019
Bryant Ranch Prepack7tablet, film coatedGeneric drugs (ANDA)April 24, 2019
Preferred Pharmaceuticals Inc.5tablet, film coatedGeneric drugs (ANDA)July 22, 2026
Accord Healthcare Inc.4tablet, film coatedGeneric drugs (ANDA)October 31, 2016
AiPing Pharmaceutical, Inc.4tablet, coatedGeneric drugs (ANDA)January 30, 2026
Aphena Pharma Solutions - Tennessee, LLC4tablet, film coatedGeneric drugs (ANDA)April 24, 2019
AstraZeneca Pharmaceuticals LP4tablet, film coatedNew drug applications (NDA)May 9, 2022
Camber Pharmaceuticals, Inc.4tablet, film coatedGeneric drugs (ANDA)October 29, 2016
Golden State Medical Supply, Inc.4tablet, film coatedGeneric drugs (ANDA)April 24, 2019
Macleods Pharmaceuticals Limited4tabletGeneric drugs (ANDA)November 6, 2024
Quallent Pharmaceuticals Health LLC4tablet, film coatedGeneric drugs (ANDA)December 15, 2025
Remedyrepack Inc.4tablet, film coatedGeneric drugs (ANDA)March 19, 2025
ScieGen Pharmaceuticals, Inc.4tablet, film coatedGeneric drugs (ANDA)April 24, 2019
AvPAK3tablet, film coatedGeneric drugs (ANDA)December 14, 2018
Cardinal Health 107, LLC2tablet, film coatedGeneric drugs (ANDA)October 16, 2025
Coupler LLC1tablet, film coatedGeneric drugs (ANDA)December 16, 2025
Direct_Rx1tablet, film coatedGeneric drugs (ANDA)December 10, 2019
NuCare Pharmaceuticals,Inc.1tablet, film coatedGeneric drugs (ANDA)April 24, 2019
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)October 29, 2016

Dosage forms

Dosage formProductsShare
Tablet, film coated6188.4%
Tablet, coated45.8%
Tablet45.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)6594.2%
New drug applications (NDA)45.8%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.